News

Prototype of a Gaucher disease point-scoring system successfully tested in Finnish patients

15.3.2021
Prototype of a Gaucher disease point-scoring system successfully tested in Finnish patients

A prototype of ...

RWD | From todays treatment to future medicine

9.3.2021

Year 2021 will be the year of Real-Wold Evidence. Data obtained from patients’ treatment has ...

Health from Data | New RWE blog starting

9.3.2021

This March marks the start of my new blog - Health From Data. Here I ...

New RWE themed blog to start in March!

23.2.2021
Interested in RWE research?

Health from data is the first real-world evidence themed blog written ...

Finnish ecosystem supports the use of real world evidence (RWE)

17.12.2020
RWE ecosystem in Finland

Real world data (RWD) is defined by FDA as “the data ...

Market access, pricing and reimbursement of medicines in Finland

17.11.2020
Market Access, pricing and reimbursement of medicines in Finland

Medicines in Finland are divided into ...

Prototype of a Gaucher disease point-scoring system successfully tested in Finnish patients

15.3.2021
Prototype of a Gaucher disease point-scoring system successfully tested in Finnish patients

A prototype of ...

RWD | From todays treatment to future medicine

9.3.2021

Year 2021 will be the year of Real-Wold Evidence. Data obtained from patients’ treatment has ...

Health from Data | New RWE blog starting

9.3.2021

This March marks the start of my new blog - Health From Data. Here I ...

New RWE themed blog to start in March!

23.2.2021
Interested in RWE research?

Health from data is the first real-world evidence themed blog written ...

Finnish ecosystem supports the use of real world evidence (RWE)

17.12.2020
RWE ecosystem in Finland

Real world data (RWD) is defined by FDA as “the data ...

Market access, pricing and reimbursement of medicines in Finland

17.11.2020
Market Access, pricing and reimbursement of medicines in Finland

Medicines in Finland are divided into ...

Medaffcon on Twitter

13.04.2021 4:39
Digiratkaisujen odotetaan tuovan apua moniin #sote'n haasteisiin, mutta tietoa niiden kustannushyödyistä tai vaikuttavuudesta on varsin vähän tarjolla. Arviointi kiinnostaa sote-organisaatioita, mutta toistaiseksi se on jäänyt vähälle.

#vaikuttavuus

https://t.co/hM7P8LDsQi
31.03.2021 8:04
Our latest study on #multiplemyeloma (MM) aimed at gaining understanding of epidemiological characteristics, treatment and survival outcomes of MM by utilizing multiple #realworlddata sources in Finland. A study collaboration with Takeda.
#RWE #RWD
https://t.co/Vx8f93tG21
15.03.2021 9:07
Prototype of #GaucherDisease point-scoring system was successfully tested in Finnish patients. Feasibility of identifying undiagnosed patients by point-scoring large #EHR data sets by #datamining was also evaluated. https://t.co/WjH9pF2LV6
#realworldevidence #rwe #raredisease https://t.co/V9uvfckeiG

Medaffcon on Youtube

Medaffcon’s news archive

News Archive »

At Medaffcon, we are devoted to providing means for data-driven decision-making in healthcare and working towards economically sustainable, effective and more individualized treatment care. We believe that Finland is at the forefront of developing tomorrow’s healthcare and mapping the treatment paths of the future. Future Care Finland website was born from the desire to share these visions with all people interested in future healthcare and wellbeing.

Read more »